Professor Liz Sockett, from the University of Notttingham’s School of Life Sciences and co-lead author of the paper, said: ”Checking the timing of when the Bdellovibrio used each of its lysozymes in predation, and hours at the microscope seeing what happened to prey-escape when each lysozyme was missing, gave us strong hunch which might be the important one for escape.”
“When we looked closely at the lysozyme it was clear we were on the right path,” says Dr Lovering. “It looked like a conventional lysozyme but with a warped active site, which meant it was unable to recognise the wall material unless it had been modified and marked by the Bdellovibrio bacteria.”
The next step was to confirm that the lysozyme was only active against the modified cell wall and the team worked with Dr Patrick Moynihan, also in the School of Biosciences at the University of Birmingham, on tests to verify this. This showed it to be a novel lysozyme with a different target to all those lysozymes previously studied in science.
Dr Simona Huwiler, in Professor Sockett’s lab then carried out a series of experiments with the predator bacteria showing clearly how adding this novel lysozyme during the predation process led to the predator falling out from the prey cell early before finishing its meal. So the novel lysozyme is the key to exit.
“Understanding the mechanism and actions of this novel lysozyme may help us use it directly against pathogens which modify their own cell walls to resist the lysozymes in saliva and tears. It is also an important step towards being able to use predatory bacteria themselves in new therapies against problematic bacteria,” adds Professor Sockett.
The research was funded by the Biotechnology and Biological Sciences Research Council and by a fellowship to Dr Huwiler from the Swiss National Science Foundation. Ongoing work is funded by the Wellcome Trust.